Cyrille Leperlier
Vermögen: - $ am 31.03.2024
Vermögen: - $ am 31.03.2024
Cyrille Raymond George Leperlier is currently an Independent Non-Executive Director at NuCana Plc since 2018.
Formerly, the role of Chief Executive Officer was held at Divlal SAS from 2020 to 2022.
The position of Medical Director was held at Rhone-Poulenc Rorer, Inc. Medical Director at Sanofi-Aventis Japan was held from 2014 to 2019.
Education includes graduate and doctorate degrees from the University of Paris Jussieu.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NUCANA PLC -.--% | 18.03.2026 | 0 ( -.--% ) | - $ | 31.03.2024 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NUCANA PLC | Direktor/Vorstandsmitglied | 01.05.2018 |
| Unternehmen | Position | Ende |
|---|---|---|
Divlal SAS | Vorstandsvorsitzender | 01.11.2022 |
Sanofi-Aventis Japan | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2019 |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
University of Paris Jussieu
University of Paris Jussieu Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi-Aventis Japan | |
NuCana Plc
NuCana Plc BiotechnologyHealth Technology Develops and commercializes novel anti-cancer medicines | Health Technology |
Divlal SAS |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen